Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL88159 | 0.83 | — | — | |
| SCHEMBL6121060 | 0.79 | GAA (0.44) | GAATSHRTTRALDH1A1LMNA | |
| SCHEMBL1933467 | 0.79 | GAA (0.44) | GAATSHRTTRALDH1A1LMNA | |
| Dioxane SCHEMBL6669275 | 0.79 | GAA (0.44) | GAATSHRTTRALDH1A1LMNA | |
| SCHEMBL7200305 | 0.79 | GAA (0.44) | GAATSHRTTRALDH1A1LMNA | |
| SCHEMBL29008 | 0.75 | — | — | |
| SCHEMBL4394616 | 0.75 | — | — | |
| SCHEMBL278292 | 0.75 | LMNA (0.42) | GAATSHRALDH1A1LMNATP53 | |
| SCHEMBL1933520 | 0.75 | LMNA (0.42) | GAATSHRALDH1A1LMNATP53 | |
| Methane SCHEMBL29072799 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2111237-B1 | FIBRIN-BINDING PEPTIDES AND CONJUGATES THEREOF | BRACCO IMAGING SPA (IT) | 2015-03-18 | — | — | EP | disclosed |
| US-8278274-B2 | Fibrin-binding peptides and conjugates thereof | BRACCO IMAGING SPA (IT) | 2012-10-02 | — | — | US | disclosed |
| US-20100158814-A1 | Fibrin-Binding Peptides and Conjugates Thereof | BRACCO IMAGING S.P.A. (IT) | 2010-06-24 | — | — | US | disclosed |
| EP-2111237-A2 | FIBRIN-BINDING PEPTIDES AND CONJUGATES THEREOF | BRACCO IMAGING S.p.A. (IT) | 2009-10-28 | — | — | EP | disclosed |
| WO-2008073458-A2 | FIBRIN-BINDING PEPTIDES AND CONJUGATES THEREOF | BRACCO IMAGING S.P.A. (IT) | 2008-06-19 | — | — | WO | disclosed |
| EP-0534772-A2 | Oxidising compositions | WARWICK INTERNATIONAL GROUP LIMITED(Company No. 2754514) (GB) | 1993-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100158814-A1 | Fibrin-Binding Peptides and Conjugates Thereof | FGB, F13B, F13A1 | GAA 2907/4885TSHR 1126/4885TTR 198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.